Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV10 booster versus PCV13 booster at 12 months after infant PCV13 priming
ISRCTN57878347Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Apr 2012
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, open-label trial in pneumococcal disease comparing PCV10 booster arm with PCV13 booster arm (2 arms). Primary endpoint: Immunogenicity of booster vaccination. Started Apr 2012; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on ISRCTN57878347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN57878347.